Unified Patent Court (UPC) analytics are now available. Check here

EP2662094

ONYX THERAPEUTICS
Application Number
EP13167148A
Filing Date
May 8, 2013
Status
Granted And Under Opposition
Mar 15, 2024
Grant Date
Apr 17, 2024
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP2662094B1 was granted on Apr 17, 2024 by Onyx Therapeutics The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRAND MURRAY FULLERJan 17, 2025ADMISSIBLE
HGFJan 17, 2025ADMISSIBLE
RUMIJan 17, 2025ADMISSIBLE
STADA ARZNEIMITTELJan 17, 2025ADMISSIBLE
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBJan 17, 2025ADMISSIBLE
FRESENIUS KABI DEUTSCHLANDJan 9, 2025ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.